Position in AMGN
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$3,223,954
+$74,899 QoQ
Shares Held
8,903
-0.5% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.48%
of 13F equity value
Holder Rank
#1,037
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026First PREMIER Bank holds $19,058,988 across 11 Drug Manufacturers - General names. AMGN ranks #2 (16.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
36,024 | $9,149,013 | |
| 2 | AMGN |
Amgen Inc
This page
|
8,903 | $3,223,954 | |
| 3 | MRK |
Merck & Co., Inc.
|
21,539 | $2,767,761 | |
| 4 | ABBV |
AbbVie Inc.
|
6,697 | $1,685,232 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
5,692 | $719,126 | |
| 6 | LLY |
ELI LILLY & Co
|
538 | $645,292 | |
| 7 | PFE |
Pfizer Inc
|
15,632 | $376,417 | |
| 8 | GSK |
GSK plc
|
4,433 | $232,377 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,223,954 | 8,903 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $3,149,055 | 8,950 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $2,956,917 | 9,034 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $2,590,313 | 9,179 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $2,582,412 | 9,249 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $2,919,222 | 9,370 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $2,442,195 | 9,370 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $3,025,550 | 9,390 | Shares | Sole | 2024-10-08 | |
| 2024-06-30 | $2,986,708 | 9,559 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $2,733,450 | 9,614 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $2,800,705 | 9,724 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $2,639,759 | 9,822 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $2,229,301 | 10,041 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $2,487,848 | 10,291 | Shares | Sole | 2023-04-10 | |
| 2022-12-31 | $2,759,293 | 10,506 | Shares | Sole | 2023-01-17 | |
| 2022-09-30 | $2,376,392 | 10,543 | Shares | Sole | 2022-10-20 | |
| 2022-06-30 | $2,554,649 | 10,500 | Shares | Sole | 2022-07-26 | |
| 2022-03-31 | $2,546,362 | 10,530 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $2,323,938 | 10,330 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $2,180,725 | 10,255 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $2,499,655 | 10,255 | Shares | Sole | 2021-07-14 | |
| 2021-03-31 | $2,395,789 | 9,629 | Shares | Sole | 2021-04-12 | |
| 2020-12-31 | $2,213,898 | 9,629 | Shares | Sole | 2021-01-12 | |
| 2020-09-30 | $2,508,812 | 9,871 | Shares | Sole | 2020-10-06 | |
| 2020-06-30 | $2,328,172 | 9,871 | Shares | Sole | 2020-07-07 | |
| 2020-03-31 | $1,955,531 | 9,646 | Shares | Sole | 2020-04-08 | |
| No filing history on record for this holder in this stock. | ||||||